Market Highlights

• GRIN Therapeutics, a top-funded neurodevelopmental drugmaker this quarter, partnered with Angelini Pharma to develop and commercialize its treatment outside North America, where it is being studied to treat neurodevelopmental disorders.
• Biotech company Cresilon recently expanded, while Rumi Scientific signed a new lease and relocated to Brooklyn’s Industry City.
• New York Institute of Technology (NYIT) opened the 20,000-square-foot (sf) Biomedical Research, Innovation, and Imaging Center (BRIIC) on its Long Island campus, which will enhance its research capabilities and expands the school’s scientific footprint.

Read the full report